Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1974 Feb;50(2):227–230. doi: 10.1111/j.1476-5381.1974.tb08565.x

Inhibition of the prostaglandin synthetase systems in ocular tissues by indomethacin

P Bhattacherjee, KE Eakins
PMCID: PMC1776635  PMID: 4425761

Abstract

1 We have compared the sensitivity of the prostaglandin synthetase systems derived from microsomal fractions of rabbit ocular tissues (anterior uvea, conjunctiva and retina) with other rabbit tissues such as the kidney medulla and spleen, to inhibition by indomethacin.

2 Generation of prostaglandin-like activity by the microsomal fractions from added arachidonic acid varied with the tissue used. Highest activity was found in the kidney medulla, then in descending order, the conjunctiva, anterior uvea, spleen, retina and cornea.

3 Indomethacin was most potent in the spleen (ID50 0.045 μg/ml) then in decreasing order in the kidney medulla, conjunctiva, anterior uvea and weakest in the retina, where the ID50 for indomethacin was 50 μg/ml.

4 The differential sensitivity to inhibition of the prostaglandin synthetase systems from different tissues is an important consideration in the development of new ocular anti-inflammatory agents.

Full text

PDF
227

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambache N., Brummer H. C. A simple chemical procedure for distinguishing E from F prostaglandins, with application to tissue extracts. Br J Pharmacol Chemother. 1968 May;33(1):162–170. [PubMed] [Google Scholar]
  2. Beitch B. R., Eakins K. E. The effects of prostaglandins on the intraocular pressure of the rabbit. Br J Pharmacol. 1969 Sep;37(1):158–167. doi: 10.1111/j.1476-5381.1969.tb09533.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bethel R. A., Eakins K. E. The mechanism of the antagonism of experimentally induced ocular hypertension by polyphloretin phosphate. Exp Eye Res. 1972 Jan;13(1):83–91. doi: 10.1016/0014-4835(72)90128-5. [DOI] [PubMed] [Google Scholar]
  4. Bito L. Z., Salvador E. V. Intraocular fluid dynamics. 3. The site and mechanism of prostaglandin transfer across the blood intraocular fluid barriers. Exp Eye Res. 1972 Nov;14(3):233–241. doi: 10.1016/0014-4835(72)90008-5. [DOI] [PubMed] [Google Scholar]
  5. Eakins K. E. Increased intraocular pressure produced by prostaglandins E1 and E2 in the cat eye. Exp Eye Res. 1970 Jul;10(1):87–92. doi: 10.1016/s0014-4835(70)80014-8. [DOI] [PubMed] [Google Scholar]
  6. Eakins K. E., Whitelocke R. A., Perkins E. S., Bennett A., Unger W. G. Release of prostaglandins in ocular inflammation in the rabbit. Nat New Biol. 1972 Oct 25;239(95):248–249. doi: 10.1038/newbio239248a0. [DOI] [PubMed] [Google Scholar]
  7. Ferreira S. H., Moncada S., Vane J. R. Indomethacin and aspirin abolish prostaglandin release from the spleen. Nat New Biol. 1971 Jun 23;231(25):237–239. doi: 10.1038/newbio231237a0. [DOI] [PubMed] [Google Scholar]
  8. Flower R., Gryglewski R., Herbaczyńska-Cedro K., Vane J. R. Effects of anti-inflammatory drugs on prostaglandin biosynthesis. Nat New Biol. 1972 Jul 26;238(82):104–106. doi: 10.1038/newbio238104a0. [DOI] [PubMed] [Google Scholar]
  9. Higgs G. A., Youlten L. J. Proceedings: Prostaglandin production by rabbit peritoneal polymorphonuclear leukocytes in vitro. Br J Pharmacol. 1972 Feb;44(2):330P–330P. [PMC free article] [PubMed] [Google Scholar]
  10. Kelly R. G., Starr M. S. Effects of prostaglandins and a prostaglandin antagonist on intraocular pressure and protein in the monkey eye. Can J Ophthalmol. 1971 Jul;6(3):205–211. [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. Miller J. D., Eakins K. E., Atwal M. The release of PGE2-like activity into aqueous humor after paracentesis and its prevention by aspirin. Invest Ophthalmol. 1973 Dec;12(12):939–942. [PubMed] [Google Scholar]
  13. Perkins E. S., MacFaul P. A. Indomethacin in the treatment of uveitis. A double-blind trial. Trans Ophthalmol Soc U K. 1965;85:53–58. [PubMed] [Google Scholar]
  14. Smith J. B., Willis A. L. Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol. 1971 Jun 23;231(25):235–237. doi: 10.1038/newbio231235a0. [DOI] [PubMed] [Google Scholar]
  15. Starr M. S. Effects of prostaglandin on blood flow in the rabbit eye. Exp Eye Res. 1971 Mar;11(2):161–169. doi: 10.1016/s0014-4835(71)80019-2. [DOI] [PubMed] [Google Scholar]
  16. Starr M. S. Further studies on the effect of prostaglandin on intraocular pressure in the rabbit. Exp Eye Res. 1971 Mar;11(2):170–177. doi: 10.1016/s0014-4835(71)80020-9. [DOI] [PubMed] [Google Scholar]
  17. Unger W. G., Stamford I. F., Bennett A. Extraction of prostaglandins from human blood. Nature. 1971 Oct 1;233(5318):336–337. doi: 10.1038/233336b0. [DOI] [PubMed] [Google Scholar]
  18. VANE J. R. A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol Chemother. 1957 Sep;12(3):344–349. doi: 10.1111/j.1476-5381.1957.tb00146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
  20. van Dorp D. A., Jouvenaz G. H., Struijk C. B. The biosynthesis of prostaglandin in pig eye iris. Biochim Biophys Acta. 1967 Apr 4;137(2):396–399. doi: 10.1016/0005-2760(67)90117-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES